CHANGZHOU HI-TECH DISTRICT MULTIPLE DIMENSION INDU
发明人:
Hebing XIE,Qingyi LI,Shuhua GU,Weihong LV
申请号：
US15857494
公开号：
US20180117036A1
申请日:
2017.12.28
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to an oral pharmaceutical composition for increasing hypoxia tolerance, characterized in that the pharmaceutical composition comprises active ingredient L-carnitine or derivative thereof or pharmaceutically acceptable salt thereof, active ingredient trimetazidine or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable auxiliary material, and 100:1 is the weight ratio of L-carnitine or derivative thereof or pharmaceutically acceptable salt thereof and trimetazidine or pharmaceutically acceptable salt thereof.
